Target
Anthracyclines
21 abstracts
Abstract
Predicting epirubicin response in Danish patients with breast cancer.Org: Aida Oncology, Dragor, Denmark, JADBio, Crete, Greece, Raven Biosciences,
Abstract
Improving chemotherapy-induced alopecia for women receiving anthracycline plus taxane chemotherapy using the Paxman scalp cooling system at lower temperatures.Org: Memorial Sloan Kettering Cancer Center, New York, NY, Dermatology Service, NYU Langone Health, New York, NY,
Abstract
Deep learning with whole slides images to predict histological response to neoadjuvant chemotherapy in patients with resectable high grade soft-tissue sarcomas: A multicenter study.Org: OWKIN, Bergonié Institute, Centre Léon Bérard, Institut Bergonié,
Abstract
Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial.Org: Oncology Institute of Southern Switzerland, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland, University of Southampton,
Abstract
Differential benefit of capecitabine-based chemotherapy among TNBC subtypes in the context of the CBCSG010 study.Org: Shanghai Cancer Center, Shanghai, China, Fudan University Shanghai Cancer Center, Department of Breast Surgery, Kyorin University School of Medicine/Saitama Medical Center, Tokyo, Japan, Key Laboratory of Breast Cancer in Shanghai, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy,
Abstract
Prospective cardiovascular surveillance of immune checkpoint inhibitor-based combination therapy in patients with early-stage, triple-negative breast cancer.Org: University of Texas Southwestern Medical Center, UT Southwestern Medical Center,
Abstract
Clinical outcomes of patients with newly diagnosed acute myeloid leukemia receiving treatment in a safety-net hospital system.Org: Baylor College of Medicine, University of Texas MD Anderson Cancer Center,
Abstract
Use of PLR and NLR to evaluate the efficacy and prognosis of neoadjuvant chemotherapy with lobaplatin in triple-negative breast cancer.Org: Southwest Hospital Army Medical University, Army Medical University, Chongqing Precision Biotech, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University; Key Laboratory of Minimally Invasive Surgery and Precision Treatment for Breast Cancer of Chongqing Municipal Health Commission, Chongqing, China, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China, Department of Breast and Thyroid Surgery, Sounthwest Hospital, Army Medical University, Chongqing, China, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University; Department of Thoracic Surgery, the Eighth Medical Center of Chinese PLA General Hospital, Chongqing, China, Central Medical Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. L., Nanjing, China, 29 Gaotanyan Main Street,
Abstract
Neoadjuvant single-dose trilaciclib prior to combination chemotherapy in patients with early triple-negative breast cancer: Safety, efficacy, and immune correlate data from a phase 2 study.Org: Department of Medicine, Duke University School of Medicine, Texas Oncology-Baylor Charles A. Sammons Cancer Center, PIH Health Whittier Hospital, Nebraska Hematology-Oncology P.C., Division of Hematology/Oncology, David Geffen School of Medicine at the University of California Los Angeles/Jonsson Comprehensive Cancer Center,
Abstract
Treatment and treatment-related toxicity following subsequent breast cancer: A report from the Childhood Cancer Survivor Study (CCSS).Org: University of Minnesota Masonic Cancer Center, Minneapolis, MN, St. Jude Children's Research Hospital, University of Chicago Medicine, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, Northwestern Medicine Lake Forest Hospital,
Abstract
Efficacy of paxman scalp cooling system at lower temperatures for prevention of anthracycline associated chemotherapy induced alopecia.Org: Memorial Sloan Kettering Cancer Center,
Abstract
Older patients with early-stage triple-negative breast cancer: The Memorial Sloan Kettering Cancer Center experience.Org: Memorial Sloan Kettering Cancer Center,
Abstract
Tumor-infiltrating lymphocytes (TILs) for prediction of response to platinum-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC).Org: N.N. Petrov National Research Oncology Institute, N.N. Petrov National Medical Research Center of Oncology, N.N. Petrov National Medicine Research Center of Oncology, Pavlov First Saint Petersburg State Medical University,
Abstract
Treatment patterns and clinical outcomes of newly diagnosed early-stage and locally advanced triple negative breast cancer (TNBC): A retrospective cohort analysis of national real-world data in England.Org: Merck Sharp & Dohme, London Regional Cancer Center, Merck Sharpe & Dohme, Adelphi Real World, Bollington,
Abstract
Social determinants of health as a primary driver in outcomes in acute myeloid leukemia: An urban academic center experience.Org: VCU Massey Cancer Center, VCU School of Medicine, VCU Department of Internal Medicine, VCU Department of Biostatistics,
Abstract
Efficacy comparison of anthracycline and taxane when added to immune checkpoint inhibitor in neoadjuvant chemotherapy of triple negative breast cancer: Clinical evidence from size-reduction measurement by ultrasound.Org: Chang Gung Memorial Hospital at Taipei, Chang Gung University Medical College, Chang Gung Memorial Hospital, Department of General Surgery, Chang Gung Memorial Hospital at Tao-Yuan, Tao-Yuan, Taiwan, Department of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL,
Abstract
Characterization of drug and non-drug interactions in patients treated in medical oncology.Org: Faculty of Medicine, University of Tlemcen, Department of Medicine, Laboratoire Toxicomed, University of Tlemcen, Department of Medical Oncology, CHU Tlemcen,
Abstract
Falls and hospitalization during chemotherapy in older women with early breast cancer.Org: City of Hope National Medical Center, Duarte, CA, University of Nebraska Medical Center, Omaha NE, Neurocentria,
Abstract
Protective effect of the dexrazoxane against cardiotoxicity of the anthracycline in the treatment of the childhood cancers.Org: Ankara University, School of Medicine Department of Pedaitric Oncology, Department of Pediatric Cardiology, Ankara University Faculty of Medicine, Department of Pediatrics - Division of Pediatric Hematology-Oncology,
Abstract
An evaluation of cisplatin, doxorubicin, and cyclophosphamide (PAC) compared to other regimens for patients with unresectable or metastatic thymic carcinoma: A single-institution retrospective analysis.Org: Indiana University School of Medicine and Regenstrief Institute, Indianapolis, IN, Indiana University Melvin and Bren Simon Comprehensive Cancer Center,
Abstract
Uterine sarcoma patients who underwent morcellation: Who are they? Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA- NOGGO RU1).Org: Charité - Universitätsmedizin Berlin, Berlin, Germany, Helios Klinikum Berlin-Buch, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, Tuebingen University Hospital,